Boris Peaker
Stock Analyst at Jones Trading
(2.10)
# 3,026
Out of 5,237 analysts
20
Total ratings
36.36%
Success rate
11.39%
Average return
Main Sectors:
Stocks Rated by Boris Peaker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JANX Janux Therapeutics | Maintains: Buy | $50 → $28 | $14.23 | +96.77% | 1 | Apr 28, 2026 | |
| RLAY Relay Therapeutics | Initiates: Hold | $18 | $12.85 | +40.08% | 1 | Apr 14, 2026 | |
| MGNX MacroGenics | Downgrades: Hold | n/a | $2.95 | - | 3 | May 10, 2024 | |
| LNTH Lantheus Holdings | Initiates: Outperform | $100 | $94.07 | +6.30% | 1 | Dec 4, 2023 | |
| ADCT ADC Therapeutics | Downgrades: Market Perform | n/a | $3.48 | - | 1 | Nov 9, 2023 | |
| PCRX Pacira BioSciences | Upgrades: Outperform | $50 | $22.74 | +119.88% | 1 | Aug 3, 2023 | |
| PCVX Vaxcyte | Initiates: Outperform | n/a | $53.99 | - | 1 | Apr 18, 2023 | |
| XNCR Xencor | Initiates: Outperform | n/a | $12.79 | - | 1 | Dec 6, 2022 | |
| EBS Emergent BioSolutions | Maintains: Market Perform | $30 → $29 | $8.95 | +224.02% | 1 | Sep 12, 2022 | |
| CTMX CytomX Therapeutics | Downgrades: Market Perform | n/a | $3.86 | - | 2 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $78.72 | - | 1 | Mar 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $125.64 | - | 1 | Jul 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $813.28 | - | 1 | Jun 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $95 → $102 | $111.28 | -8.34% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.97 | - | 1 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.18 | - | 1 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $39.31 | - | 1 | Oct 22, 2018 |
Janux Therapeutics
Apr 28, 2026
Maintains: Buy
Price Target: $50 → $28
Current: $14.23
Upside: +96.77%
Relay Therapeutics
Apr 14, 2026
Initiates: Hold
Price Target: $18
Current: $12.85
Upside: +40.08%
MacroGenics
May 10, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.95
Upside: -
Lantheus Holdings
Dec 4, 2023
Initiates: Outperform
Price Target: $100
Current: $94.07
Upside: +6.30%
ADC Therapeutics
Nov 9, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $3.48
Upside: -
Pacira BioSciences
Aug 3, 2023
Upgrades: Outperform
Price Target: $50
Current: $22.74
Upside: +119.88%
Vaxcyte
Apr 18, 2023
Initiates: Outperform
Price Target: n/a
Current: $53.99
Upside: -
Xencor
Dec 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $12.79
Upside: -
Emergent BioSolutions
Sep 12, 2022
Maintains: Market Perform
Price Target: $30 → $29
Current: $8.95
Upside: +224.02%
CytomX Therapeutics
Jul 11, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $3.86
Upside: -
Mar 15, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $78.72
Upside: -
Jul 29, 2021
Initiates: Outperform
Price Target: n/a
Current: $125.64
Upside: -
Jun 12, 2017
Initiates: Outperform
Price Target: n/a
Current: $813.28
Upside: -
Jun 27, 2022
Maintains: Market Perform
Price Target: $95 → $102
Current: $111.28
Upside: -8.34%
Mar 3, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $1.97
Upside: -
Aug 13, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.18
Upside: -
Oct 22, 2018
Initiates: Outperform
Price Target: n/a
Current: $39.31
Upside: -